Smith & Nephew plc logo
Smith & Nephew plc SNN
$ 36.35 -1.06%

Annual report 2024
added 02-28-2026

report update icon

Smith & Nephew plc Gross Profit 2011-2026 | SNN

Gross profit is a key indicator of how efficiently a company produces or sells its products. This metric helps assess a business’s ability to generate revenue at the initial stage, before accounting for all other expenses. Regular analysis of gross profit allows companies to respond in a timely manner to changes in cost of goods, pricing strategy, and market conditions.

Calculation formula:
Gross Profit = Revenue – Cost of Goods Sold (COGS)

Revenue — all cash inflows from the sale of goods or services.
Cost of Goods Sold — direct costs related to the production or acquisition of goods:
  • Raw materials and supplies
  • Wages of production personnel
  • Depreciation of equipment
  • Transportation and warehousing costs (if directly related to production)
Importance for business:
  • Assessing core business profitability
    If gross profit is declining, it may indicate rising production costs or falling sales.
  • Financial planning
    Gross profit is the basis for calculating other key metrics, such as operating and net profit.
  • Benchmarking against competitors
    Gross profit analysis helps compare the efficiency of different companies within the same industry.
  • Insights into pricing effectiveness
    If gross profit is low, the company may be pricing too low or failing to control costs effectively.
Reasons for a decline in gross profit:
  • Increase in raw material and supply costs
  • Rising production expenses
  • Price reductions due to competition
  • Decrease in sales volume
  • Currency exchange rate fluctuations (for imports/exports)

Gross profit is an important metric, but it does not provide a complete picture of a company’s financial health, as it does not account for administrative and selling expenses, taxes, debt burden, or depreciation.

Annual Gross Profit Smith & Nephew plc

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
4.05 B 3.82 B 3.68 B 3.67 B 3.16 B 3.8 B 3.61 B 3.52 B 3.4 B 3.49 B 3.46 B 3.25 B 3.07 B 3.13 B

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
4.05 B 3.07 B 3.51 B

Gross Profit of other stocks in the Medical devices industry

Issuer Gross Profit Price % 24h Market Cap Country
Viemed Healthcare Viemed Healthcare
VMD
155 M $ 9.06 1.23 % $ 347 M usaUSA
Acutus Medical Acutus Medical
AFIB
-3.14 M - -26.83 % $ 2.62 M usaUSA
Allied Healthcare Products Allied Healthcare Products
AHPI
443 K - 3.58 % $ 2.21 M usaUSA
GenMark Diagnostics, Inc. GenMark Diagnostics, Inc.
GNMK
67.9 M - - $ 1.77 B usaUSA
Aziyo Biologics Aziyo Biologics
AZYO
11.1 M - 1.37 % $ 20.5 M usaUSA
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.
OBLN
584 K - -5.86 % $ 30.6 M usaUSA
Bruker Corporation Bruker Corporation
BRKR
1.65 B $ 38.78 -1.25 % $ 5.78 K usaUSA
Cognyte Software Ltd. Cognyte Software Ltd.
CGNT
247 M $ 8.15 4.22 % $ 585 M israelIsrael
Conformis Conformis
CFMS
23.2 M - - $ 16.4 M usaUSA
AdaptHealth Corp. AdaptHealth Corp.
AHCO
89.3 M $ 9.69 3.09 % $ 1.31 B usaUSA
Apollo Endosurgery Apollo Endosurgery
APEN
42.4 M - - $ 475 M usaUSA
EDAP TMS S.A. EDAP TMS S.A.
EDAP
26.6 M $ 4.15 4.01 % $ 155 M franceFrance
Cardiovascular Systems Cardiovascular Systems
CSII
173 M - 0.15 % $ 844 M usaUSA
CONMED Corporation CONMED Corporation
CNMD
750 M $ 43.13 -0.43 % $ 1.34 B usaUSA
Cutera Cutera
CUTR
-12.7 M - -10.19 % $ 1.99 M usaUSA
CryoLife, Inc. CryoLife, Inc.
CRY
168 M - -4.14 % $ 702 M usaUSA
Avinger Avinger
AVGR
2 M - -20.74 % $ 369 K usaUSA
AxoGen AxoGen
AXGN
167 M $ 29.17 -2.21 % $ 1.34 B usaUSA
Apyx Medical Corporation Apyx Medical Corporation
APYX
33.8 M $ 3.31 4.42 % $ 115 M usaUSA
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
198 M - - $ 3.31 B usaUSA
Dynatronics Corporation Dynatronics Corporation
DYNT
6.01 M - 14.99 % $ 929 K usaUSA
Eargo Eargo
EAR
14.3 M - - $ 10.2 M usaUSA
Electromed Electromed
ELMD
50 M $ 24.26 1.17 % $ 205 M usaUSA
Hancock Jaffe Laboratories, Inc. Hancock Jaffe Laboratories, Inc.
HJLI
4.25 K - -1.98 % $ 98.3 M usaUSA
Itamar Medical Ltd. Itamar Medical Ltd.
ITMR
28.7 M - 0.03 % $ 1.58 B israelIsrael
Second Sight Medical Products Second Sight Medical Products
EYES
500 K - -0.97 % $ 54.4 M usaUSA
Accuray Incorporated Accuray Incorporated
ARAY
147 M $ 0.53 0.68 % $ 54.5 M usaUSA
Misonix, Inc. Misonix, Inc.
MSON
43.7 M - - $ 462 M usaUSA
Neovasc Neovasc
NVCN
1.99 M - - $ 111 M canadaCanada
FONAR Corporation FONAR Corporation
FONR
42.4 M $ 18.51 0.05 % $ 121 M usaUSA
Cytosorbents Corporation Cytosorbents Corporation
CTSO
25.1 M $ 0.79 -1.24 % $ 43 M usaUSA
Align Technology Align Technology
ALGN
2.8 B $ 183.14 0.27 % $ 13.7 B usaUSA
Intersect ENT, Inc. Intersect ENT, Inc.
XENT
50.2 M - - $ 955 M usaUSA
Butterfly Network Butterfly Network
BFLY
48.8 M $ 3.99 7.7 % $ 845 M usaUSA
BIOLASE BIOLASE
BIOL
16.7 M - -13.19 % $ 166 K usaUSA
Abbott Laboratories Abbott Laboratories
ABT
18.7 B $ 113.59 0.01 % $ 198 B usaUSA
InMode Ltd. InMode Ltd.
INMD
291 M $ 13.58 -0.18 % $ 878 M israelIsrael
BioSig Technologies BioSig Technologies
BSGM
229 K - 37.08 % $ 85.7 M usaUSA
Boston Scientific Corporation Boston Scientific Corporation
BSX
13.9 B $ 72.75 -1.49 % $ 108 B usaUSA
IRadimed Corporation IRadimed Corporation
IRMD
56.3 M $ 105.22 0.89 % $ 1.33 B usaUSA
IRIDEX Corporation IRIDEX Corporation
IRIX
21.8 M $ 1.42 -0.7 % $ 22.9 M usaUSA
Helius Medical Technologies Helius Medical Technologies
HSDT
61 K $ 2.31 16.67 % $ 1.4 M usaUSA
Alphatec Holdings Alphatec Holdings
ATEC
532 M $ 13.05 0.23 % $ 1.96 B usaUSA
Pulmonx Corporation Pulmonx Corporation
LUNG
62 M $ 1.46 -4.58 % $ 57.1 M usaUSA
Medigus Ltd. Medigus Ltd.
MDGS
6.68 M - 10.28 % $ 55.5 M israelIsrael
Medtronic PLC Medtronic PLC
MDT
19.6 B $ 95.96 -0.8 % $ 123 B usaUSA
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
EW
4.73 B $ 85.73 0.55 % $ 50.1 B usaUSA